[go: up one dir, main page]

FR2726005B1 - Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques - Google Patents

Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques

Info

Publication number
FR2726005B1
FR2726005B1 FR9412078A FR9412078A FR2726005B1 FR 2726005 B1 FR2726005 B1 FR 2726005B1 FR 9412078 A FR9412078 A FR 9412078A FR 9412078 A FR9412078 A FR 9412078A FR 2726005 B1 FR2726005 B1 FR 2726005B1
Authority
FR
France
Prior art keywords
psychiatric
diseases
primary
applications
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9412078A
Other languages
English (en)
Other versions
FR2726005A1 (fr
Inventor
Nathalie Chaverot
Pierre-Olivier Couraud
John Laterra
Jerome Quinonero
Francoise Roux
Arthur Donny Strosberg
Jean-Leon Tchelingerian
Lionel Vignais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIM
Original Assignee
ADIM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9412078A priority Critical patent/FR2726005B1/fr
Application filed by ADIM filed Critical ADIM
Priority to NZ293994A priority patent/NZ293994A/xx
Priority to JP8512390A priority patent/JPH10507074A/ja
Priority to EP95934188A priority patent/EP0787197A1/fr
Priority to AU36575/95A priority patent/AU715289B2/en
Priority to CA002202066A priority patent/CA2202066A1/fr
Priority to PCT/FR1995/001313 priority patent/WO1996011278A1/fr
Publication of FR2726005A1 publication Critical patent/FR2726005A1/fr
Application granted granted Critical
Publication of FR2726005B1 publication Critical patent/FR2726005B1/fr
Priority to US10/440,932 priority patent/US20040018619A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Psychology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9412078A 1994-10-10 1994-10-10 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques Expired - Fee Related FR2726005B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9412078A FR2726005B1 (fr) 1994-10-10 1994-10-10 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
JP8512390A JPH10507074A (ja) 1994-10-10 1995-10-09 内皮脳細胞の不死系とその治療上の適用
EP95934188A EP0787197A1 (fr) 1994-10-10 1995-10-09 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications therapeutiques
AU36575/95A AU715289B2 (en) 1994-10-10 1995-10-09 Immortalized lines of endothelial brain cells and therapeutic applications thereof
NZ293994A NZ293994A (en) 1994-10-10 1995-10-09 Immortalized endothelial brain cell lines and their use in therapy
CA002202066A CA2202066A1 (fr) 1994-10-10 1995-10-09 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications therapeutiques
PCT/FR1995/001313 WO1996011278A1 (fr) 1994-10-10 1995-10-09 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications therapeutiques
US10/440,932 US20040018619A1 (en) 1994-10-10 2003-05-19 Immortalized lines of endothelial brain cells and therapeutic applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412078A FR2726005B1 (fr) 1994-10-10 1994-10-10 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques

Publications (2)

Publication Number Publication Date
FR2726005A1 FR2726005A1 (fr) 1996-04-26
FR2726005B1 true FR2726005B1 (fr) 1997-01-03

Family

ID=9467723

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9412078A Expired - Fee Related FR2726005B1 (fr) 1994-10-10 1994-10-10 Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques

Country Status (7)

Country Link
EP (1) EP0787197A1 (fr)
JP (1) JPH10507074A (fr)
AU (1) AU715289B2 (fr)
CA (1) CA2202066A1 (fr)
FR (1) FR2726005B1 (fr)
NZ (1) NZ293994A (fr)
WO (1) WO1996011278A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2318379A1 (fr) * 1998-01-12 1999-07-15 Betagene, Inc. Lignees cellulaires recombinees pour le criblage de medicaments
US6093553A (en) * 1998-11-25 2000-07-25 Boehringer Ingelheim Pharmaceuticals, Inc. Immortalized brain endothelial cells
EP1135466A2 (fr) * 1998-11-30 2001-09-26 Neurotech S.A. Cellules non neuronales de mammiferes modifiees en vue du stockage et de la liberation d'un neurotransmetteur
FR2787464B1 (fr) * 1998-12-21 2003-01-10 Neurotech Compositions pharmaceutiques comprenant des cellules endotheliales immortalisees pour la detection et/ou le traitement des sources angiogeniques et tout particulierement des cancers
FR2787463B1 (fr) * 1998-12-21 2001-03-30 Neurotech Preparation de cellules de mammifere eventuellement transfectees avec un gene codant pour une substance active et les compositions les contenant
WO2000056368A1 (fr) * 1999-03-23 2000-09-28 Takara Shuzo Co., Ltd. Therapeutique genique
WO2001083716A2 (fr) * 2000-05-03 2001-11-08 Neurotech S.A. Lignees immortalisees de cellules encephaliques endotheliales et applications therapeutiques de ces dernieres

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005345A1 (fr) * 1987-12-11 1989-06-15 Whitehead Institute For Biomedical Research Modification genetique de cellules endotheliales
EP0556345B2 (fr) * 1990-10-31 2005-10-12 Cell Genesys, Inc. Vecteurs de retrovirus efficaces en therapie genique
WO1992017569A1 (fr) * 1991-04-04 1992-10-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immortalisation de cellules endotheliales
FR2681609B1 (fr) * 1991-09-24 1994-12-30 Centre Nat Rech Scient Lignees de cellules endotheliales cerebrales immortalisees, leur procede de preparation et leurs applications en tant que modele d'etude de la physiopathologie cerebrale.
US5336615A (en) * 1992-01-06 1994-08-09 Yale University Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity
AU3429993A (en) * 1992-01-10 1993-08-03 Georgetown University A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy
GB9222931D0 (en) * 1992-11-02 1992-12-16 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
CA2202066A1 (fr) 1996-04-18
WO1996011278A1 (fr) 1996-04-18
AU3657595A (en) 1996-05-02
FR2726005A1 (fr) 1996-04-26
NZ293994A (en) 1999-02-25
EP0787197A1 (fr) 1997-08-06
AU715289B2 (en) 2000-01-20
JPH10507074A (ja) 1998-07-14

Similar Documents

Publication Publication Date Title
EP0861054A4 (fr) Procede photochimique de preparation d'allogreffons et de xenogreffons pour greffes biologiques
GB2305605B (en) Pipecolic acid derivatives for the treatment of neurological disorders
AU698101B2 (en) Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
EP0769903A4 (fr) Gene pour synthase d'oxyde nitrique inductible pour le traitement de maladies
IL116998A0 (en) Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders
EP1044002A4 (fr) Procedes de traitement de troubles de la contractilite cardiaque
FR2578421B1 (fr) Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire
FR2725725B1 (fr) Procede et installation pour la purification des huiles usagees
FR2772741B1 (fr) Procede et installation d'affinage du silicium
FR2726005B1 (fr) Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
NO20014674D0 (no) Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser
EP0876149A4 (fr) Procede de traitement des troubles caracterises par une surexpression de la cytidine-desaminase ou de la desoxycytidine-desaminase
BE892882A (fr) Procede pour la prophylaxie et le traitement de l'insuffisance cerebrale
EP1058546A4 (fr) Traitement de troubles maculaires et composition appropriee
MA22278A1 (fr) Procede pour le traitement de troubles respiratoires
MA23837A1 (fr) Benzamides pour le traitement de degenerescenses neurologiques
FR2795398B1 (fr) Procede et installation pour le traitement d'effluents agricoles
EP0667157A4 (fr) Traitement symptomatique des troubles circulatoires.
EP1006801A4 (fr) Cellules de sertoli utilisees comme cellules induisant la recuperation neurologique en cas de troubles neurodegeneratifs
FR2492709B1 (fr) Procede et installation pour l'usinage de pieces en tole
FR2751637B1 (fr) Cellule d'electrocoagulation pour le traitement d'effluents
EP0833641A4 (fr) Traitement et prevention de maladies prostatiques
FR2737486B1 (fr) Procede et installation pour le traitement de boues
FR2603285B1 (fr) Procede de silylation d'imides aromatiques et silylimides ainsi prepares
FR2730989B1 (fr) Procede et installation pour le traitement des dechets graisseux

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse